"Mutant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins produced from GENES that have acquired MUTATIONS.
| Descriptor ID |
D050505
|
| MeSH Number(s) |
D12.776.602
|
| Concept/Terms |
Mutant Proteins- Mutant Proteins
- Proteins, Mutant
- Mutant Protein
- Protein, Mutant
|
Below are MeSH descriptors whose meaning is more general than "Mutant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Mutant Proteins".
This graph shows the total number of publications written about "Mutant Proteins" by people in this website by year, and whether "Mutant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 5 | 5 |
| 2007 | 1 | 8 | 9 |
| 2008 | 2 | 8 | 10 |
| 2009 | 3 | 7 | 10 |
| 2010 | 4 | 15 | 19 |
| 2011 | 6 | 20 | 26 |
| 2012 | 0 | 11 | 11 |
| 2013 | 4 | 8 | 12 |
| 2014 | 2 | 8 | 10 |
| 2015 | 2 | 7 | 9 |
| 2016 | 2 | 4 | 6 |
| 2017 | 3 | 2 | 5 |
| 2018 | 1 | 3 | 4 |
| 2019 | 4 | 3 | 7 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutant Proteins" by people in Profiles.
-
Genetic Variants in ARHGEF6 Cause Congenital Anomalies of the Kidneys and Urinary Tract in Humans, Mice, and Frogs. J Am Soc Nephrol. 2023 02 01; 34(2):273-290.
-
Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome. Brain. 2022 10 21; 145(10):3383-3390.
-
Isoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer Cells. Endocrinology. 2021 03 01; 162(3).
-
Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration. Cell Mol Life Sci. 2020 Apr; 77(7):1421-1434.
-
TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer. J Natl Cancer Inst. 2019 11 01; 111(11):1202-1215.
-
Strategy to selectively remove mutant proteins could combat neurodegeneration. Nature. 2019 11; 575(7781):57-58.
-
Calmodulin-Calcineurin Interaction beyond the Calmodulin-Binding Region Contributes to Calcineurin Activation. Biochemistry. 2019 10 01; 58(39):4070-4085.
-
Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23. Proc Natl Acad Sci U S A. 2019 08 13; 116(33):16593-16602.
-
Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. Elife. 2019 04 17; 8.
-
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia. Leukemia. 2019 11; 33(11):2575-2584.